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Sensitivity to commercial teat dips (nonoxinol-9 iodine 
complex and chlorhexidine digluconate) of 56 Staphylococcus 
(S.) aureus strains isolated from quarter milk samples of various 
German dairy herds treated with different teat dipping schemes 
was investigated in this study. The minimum inhibitory 
concentration was determined using a broth macrodilution 
method according to the German Veterinary Association 
guidelines. The main objective of the current study was to 
induce in vitro resistance induction of S. aureus to chemical 
disinfectants. Ten different strains were repeatedly passed ten 
times in growth media with sub-lethal concentrations of 
disinfectants. Nine strains showed a significant reduction in 
susceptibility to the nonoxinol-9 iodine complex but only one 
strain developed resistance to chlorhexidine digluconate. 
Stability of the acquired resistance was observed in all S. aureus 
strains adapted to the nonoxinol-9 iodine complex and 
chlorhexidine digluconate. In contrast, simultaneous resistance 
to different antibiotics was not observed in any of the ten 
investigated S. aureus strains. However, the isolates exhibited a 
high degree of resistance to penicillin G. Based on these results, 
resistance of S. aureus to chemical disinfectants may be more 
likely to develop if the chemicals are used at concentrations 
lower than that required for an optimal biocidal effect. 
Keywords: antibiotics, bovine mastitis, resistance induction, 
Staphylococcus aureus, teat dips 
Introduction
Bovine mastitis is an inflammatory reaction primarily 
caused by different pathogens that gain entry into the teat 
canal and mammary gland [3]. This represents one of the 
most costly diseases in the dairy industry worldwide with 
estimated losses of about 2 billion dollars per year in the 
United States alone [12]. These substantial economic losses 
are incurred by several factors such as rejected milk, 
reduced milk quality, drug costs, veterinary expenses, early 
culling, and increased laboratory costs [12]. Most cases of 
bovine mastitis are due to various types of bacteria. Bacteria 
of the genus Staphylococcus are one of the most common 
pathogens that cause mastitis worldwide. The genus 
Staphylococcus is divided according to the coagulase test 
into coagulase-negative (CNS) and coagulase-positive 
(CPS) species. Historically, CNS has often been considered 
to be minor important pathogens that cause intramammary 
infections (IMI). In contrast, recent studies on mastitis 
prevalence have found that CNS may be of major importance 
in some countries [3,26]. 
Staphylococcus (S.) aureus is among the CPS isolated 
from cases of bovine mastitis. This pathogen is considered 
to be one of the most common causes of bovine mastitis in 
different areas of the world and responsible for 25 ~ 30% of 
all IMI in the United States [35]. Mastitis caused by S. 
aureus is most frequently subclinical; however, major rates 
of clinical mastitis incidence are associated with this 
microorganism. S. aureus is regarded as a contagious 
mastitis pathogen because it is commonly spread from 
infected to non-infected cows during milking [33]. 
Although S. aureus is not difficult to cultivate and easily 
identified, there is still need for a rapid and sensitive 
DNA-based assay specific for detecting S. aureus [30]. 
Most recent studies used polymerase chain reaction (PCR) 
techniques to identify S. aureus and, in some cases, for 
genotyping [10,18]. In general, more rapid identification of 
bacteria using matrix-assisted laser desorption/ionization- 
time of flight-mass spectrometry (MALDI-TOF-MS) can 
be an important method for diagnosing infections [31].
Bovine S. aureus mastitis can be prevented and 
controlled by the use of effective post-milking teat 
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germicides, antibiotic application on all quarters when 
drying off, culling animals with chronic infections, 
treatment of clinical mastitis during lactation, and proper 
use of functioning milking machines [3].  Post-milking 
teat disinfection is considered to be one of the most effective 
procedures for reducing the rate of subclinical and clinical 
cases of mastitis during lactation. More than ten different 
active compounds have been used in teat disinfectants 
worldwide over the last 20 years. The National Mastitis 
Council (NMC) (USA) reviewed and summarized nearly all 
the scientific literature on teat disinfectants published since 
1980, and found that more than 10 different active 
ingredients as iodine and chlorhexidine have been used in 
teat disinfectants throughout the world [26]. Despite the 
universal acceptance of teat dipping as a method of mastitis 
control, a number of limitations are associated with most 
teat dips currently available. The most significant restriction 
is that teat dips do not provide equal protection against the 
huge amount of bacteria that cause bovine mastitis. 
Furthermore, prolonged in vitro exposure to germicidal teat 
dips has been shown to enhance the resistance of some 
bacteria to chemical disinfectants [22]. Several passages of 
bacterial isolates with sub-lethal concentrations of 
disinfectants were found to either induce resistance or select 
for resistant variants [36]. 
Some laboratory studies suggested that the development 
of resistances against biocides and antibiotics are linked 
whereas other studies failed to identify an association 
[19,29]. Microorganisms are limitlessly adaptable and 
have already demonstrated different mechanisms of 
resistance to different biocides; the concern is that these 
mechanisms may give cross-resistance to clinically 
important antibiotics. Several numbers of studies have 
been achieved to assess whether environmental and/or 
clinical strains that show decreased susceptibility to 
different types of biocides also display resistance to 
various types of antibiotics [29].
The current study was thus performed to evaluate the in 
vitro efficacy of two teat disinfectants (nonoxinol-9 iodine 
complex and chlorhexidine digluconate) and the ability of 
these compounds to induce resistance in identified strains 
of S. aureus. We also evaluated the antibiotic resistance 
patterns of S. aureus and CNS isolated from cases of 
bovine mastitis. Finally, we assessed the probability of 
cross-resistance in S. aureus to teat disinfectants and 
different types of antibiotics commonly used to treat 
bovine mastitis.
Materials and Methods
Milk samples, animals and bacterial strains 
Quarter milk samples were collected from six dairy herds 
with a high prevalence of S. aureus in the federal state of 
Brandenburg, Germany using standard procedures 
described by the NMC [19]. From each herd, 32 cows in 
different stages of lactation and different ages were chosen 
for sampling. The animals were divided into three groups 
according to teat dipping schemes. Teats of the first group 
were dipped with a post-milking teat disinfectant 
(nonoxinol-9 iodine complex), the teats of second group 
were dipped in chlorhexidine digluconate, and the third 
group did not undergo any treatment (a negative control 
group). 
A total of 70 S. aureus and CNS isolates had been 
recovered from subclinical cases of bovine mastitis during 
a survey carried out for 6 months. Isolation of all isolates 
was performed according to the NMC recommendations 
[20] for examining quarter-milk samples. S. aureus strains 
were preliminarily identified by colony morphology, 
ability to induce hemolysis, and Gram staining. Creamy, 
grayish-white, or golden-yellow colonies that were 
catalase-positive, coagulase-positive, and Gram-positive 
cocci and induced complete and/or incomplete hemolysis 
were identified as S. aureus. Specific identification of the 
S. aureus strains and CNS was made phenotypically with a 
tube coagulase test and Staph ID 32 API systems 
(BioMérieux, France), and genotypically by PCR and 
MALDI-TOF-MS. The reference S. aureus strains used for 
each trial were American Type Culture Collection 25923 
(ATCC 25923; ATCC, USA) and Deutsche Sammlung von 
Mikroorganismen 799 (DSM 799; DSM, Germany). 
Teat dips
Thirty isolates of different Staphylococcus species (17 
coagulase-positive S. aureus and 13 CNS) were derived 
from the first group of cows with teats that were regularly 
treated with a solution of nonoxinol-9 iodine complex 
(2,700 ppm as nonoxinol-9 iodine complex and less that 8% 
glecrol; Kesla, Germany). Another 30 isolates of various 
Staphylococcus species (29 coagulase-positive S. aureus 
and one CNS) were collected from a second group of cows 
with teats that were regularly dipped in a preparation of 
chlorhexidine digluconate [3,500 ppm as chlorhexidine 
digluconate along with glycerol, polysorbate 20, sodiumsalt 
(E141), chlorophyllin copper complex, and purified water; 
Eimermacher, Germany]. Finally, ten isolates of S. aureus 
were isolated from a third group of cows that had not been 
subjected to teat dipping (control group).
Broth macrodilution method for measuring the in 
vitro susceptibility of S. aureus to commercial teat dips
Serial dilutions (100, 50, 25, 12.5, 6.25, 3.12, 1.56 and 
0.78%) of disinfectant were added to tryptose soya broth 
(TSB) (Oxoid, England) inoculated with a standardized 
number (ca 1 × 108 KbE/mL) of S. aureus and incubated at 
37oC for a prescribed time (18∼24 h). Turbidity of the 
actively growing broth culture was adjusted by a 
Nephelometer (TREK Diagnostic Systems, UK) with 
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sterile saline (NaCl) to obtain a level of turbidity optically 
comparable to that of 0.5 McFarland standards (ca 1×108 
KbE/mL). The lowest concentration (highest dilution) of 
disinfectant preventing the appearance of turbidity was 
considered to be the minimum inhibitory concentration 
(MIC). This method was repeated twice in the same 
manner for the nonoxinol-9 iodine complex, chlorhexidine 
digluconate, and the negative control. 
Induction of S. aureus resistance to disinfectants 
with sub-lethal concentrations of the chemicals using 
a broth macrodilution method 
Ten different isolates of S. aureus previously tested in the 
preceding subsection with nonoxinol-9 iodine complex 
and chlorhexidine digluconate were included in this study. 
The purpose of this investigation was to compare the MIC 
of each active agent before and after ten passages. All 
strains were passed ten times in a liquid medium (TSB) 
with a sub-lethal concentration (concentration of each 
disinfectant below the MIC, where the isolates still show 
growth (12.5 and 25.0% for nonoxinol-9 iodine complex 
and chlorhexidine digluconate, respectively)) of the 
disinfectants within a 72-h interval under complete hygienic 
conditions to avoid contamination. The MIC values for the 
isolates were again determined after the tenth passage and 
compared to the original MIC values measured before 
passaging. Purity of the S. aureus cultures was evaluated 
by streaking on Mueller-Hinton agar (Oxoid, England). 
The stability of disinfectant resistance was determined by 
continuously subculturing the resistant strains in 
disinfectant-free nutrient broth (Oxoid, England). 
Subculturing was performed every 24 h for ten passages 
and MIC was measured after the tenth passage. Culture 
purity was evaluated at each passage.
Assessment of antimicrobial drug resistance of S. 
aureus strains and CNS using the agar disk diffusion 
method 
A total of 70 strains of S. aureus and CNS were evaluated 
in this experiment. Six antibiotics were chosen according 
to the frequency of use for mastitis therapy. These included 
penicillin (penicillin G and oxacillin), aminoglycosides 
(gentamycin), macrolides (erythromycin), tetracyclines 
(tetracycline), and chloramphinicol. An agar disc diffusion 
test was carried out to determine the drug susceptibility for 
all strains. Cells from four to five colonies of S. aureus 
from pure cultures were picked with a sterile loop and 
suspended in 5 mL of sterile physiologic saline (NaCl) 
solution. Turbidity of the actively growing broth culture 
(TSB) was adjusted with 5 mL of sterile saline (NaCl) to 
obtain turbidity optically comparable to that of 0.5 
McFarland standards (ca 1 × 108 KbE/mL). The entire 
surface of a Mueller-Hinton agar plate was inoculated with 
bacterial culture using a sterile swab. Disks (Mast 
Diagnostika, Germany) containing 10 I.U. penicillin G, 10 
μg gentamycin, 5 μg oxacillin, 15 μg erythromycin, 30 μg 
tetracycline, or 30 μg chloramphinicol were placed onto 
the agar surface using sterile forceps and gently pressed to 
ensure contact. The plates were incubated at 37oC for 24 h 
and the diameter of the zone of inhibition around each disk 
was then measured. The zones of growth inhibition were 
compared to the zone-size interpretative table, and all 
strains were designated as susceptible, intermediate, or 
resistant to each drug tested. The presence of colonies 
within a zone of inhibition was considered to indicate 
eventual resistance to that agent. 
Evaluation of cross-resistance to teat dips and 
antibiotics using the broth microdilution method
Cross-resistance to a panel of antibiotics was assessed 
with Sensititre plates (TREK Diagnostic Systems, UK) 
using the broth microdilution method of the Federal 
Institute for Risk Assessment (Germany) according to 
instructions M7-A8 of the Clinical Laboratory Standards 
Institute [4]. Briefly, Mueller-Hinton agar plates were 
streaked with bacterial cryobank to obtain isolated colonies 
of S. aureus. After an overnight incubation at 37oC, four or 
five isolated colonies were selected and transferred with an 
inoculating needle or loop to a tube containing 5 mL of 
sterile saline solution and vortexed thoroughly. Turbidity of 
the actively growing broth culture (TSB) was adjusted with 
sterile saline using a nephelometer (TREK Diagnostic 
Systems, UK) to obtain turbidity optically comparable to 
that of 0.5 McFarland standards (ca 1 × 105 KbE/mL) and 
then inoculate 11 mL cation adjusted Mueller-Hinton broth 
tube with 15∼50 μL of the adjusted broth culture . Screw 
the dosing head on the tube and inoculate 50 μL in each well 
of the microtitre plate (European susceptibility testing). 
The microtitre plates were sealed with foil, incubated at 
37oC for 18∼24 h, and read with a Sensititre automatic 
reader (TREK Diagnostic Systems, UK).  
Results 
All S. aureus and CNS isolates were identified 
phenotypically by a tube coagulase test and Staph ID 32 
API system, and genotypically using PCR and 
MALDI-TOF-MS (Table 1). Susceptibility of S. aureus to 
the nonoxinol-9 iodine complexes and chlorhexidine 
digluconate was measured using the broth macrodilution 
method. The MIC values of nonoxinol-9 iodine for the 
control group ranged from 41 to 46%. These values ranged 
from 41 to 49% for the dipped group. The mean MIC values 
of nonoxinol-9 iodine for the dipped and control groups 
were 45.7 ± 2.54% and 42.6 ± 1.64%, respectively. The 
MIC values of chlorhexidine digluconate for the control 
group ranged from 96 to 98% and from 95 to 99% for the 
dipped group. The mean MIC values of chlorhexidine 
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Table 1. Phenotypic, genotypic, and mass spectral identification of Staphylococcus (S.) aureus isolates and coagulase negative species 
(CNS) from cows with subclinical cases of mastitis
Staphylococcus species Number of isolates identified
Phenotypic identification Genotypic identification
Mass








































Table 2. The minimum inhibitory concentration (MIC) values of the Ujosan and Eimü chlorhexidine dips administered at sub-lethal 
concentrations before ten passages, after the tenth passage, and after the tenth stable passage of ten S. aureus strains
Strain











MIC (%)  after
10th stable passage



































































































































a: first test, b: second test, passage: passage of S. aureus with sub-lethal concentrations of the nonoxinol-9 iodine complex and chlorhexidine 
digluconate, stable passage: passage of S. aureus without active substances (nonoxinol-9 iodine complex and chlorhexidine digluconate).
digluconate for the dipped and control groups were 97.51 ± 
0.98% and 96.8 ± 0.78%, respectively. No significant 
differences (p ＜ 0.05) were observed between the dipped 
and control groups for either teat dip. 
Induction of S. aureus resistance 
Induction of resistance for S. aureus was readily achieved 
by repeated passage with sub-lethal concentrations of the 
nonoxinol-9 iodine complex and chlorhexidine digluconate 
(concentration of each disinfectant below the MIC, where 
the isolates still show growth (12.5 and 25% for nonoxinol-9 
iodine complex and chlorhexidine digluconate, respectively)). 
Nine strains of S. aureus (Table 1) showed a significant 
reduction in susceptibility to the nonoxinol-9 iodine 
complex while one strain showed a small reduction in 
susceptibility to this reagent. In contrast, susceptibility to 
chlorhexidine digluconate did not changed in any strain 
exposed to sub-lethal concentration of this compound 
except for strain F which showed a significant reduction in 
susceptibility (Table 2). The stability of acquired resistance 
was noticed in all S. aureus strains that had adapted to the 
nonoxinol-9 iodine complex and chlorhexidine digluconate. 
The percentages of S. aureus strains that developed stable 
resistance against the nonoxinol-9 iodine complex and 
chlorhexidine digluconate were 90 and 10%, respectively. 
It was impossible to increase resistance to chlorhexidine of 
most S. aureus strains via serial passage. Taken together, 
the results of this experiment support the hypothesis that 
prolonged exposure to commercial teat dips alters the 
germicidal susceptibility of S. aureus. The exception to this 
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Table 3. Percentages of in vitro susceptibility to six selected antimicrobial agents for 70 Staphylococcus species obtained from 
subclinical cases of bovine mastitis 
Antibiotic Disc concentration
Susceptibility (%) of
S. aureus (56 isolates) 
Susceptibility (%) of
CNS (14 isolates) 
Susceptibility (%) of
all isolates (70 isolates) 



































































CNS: coagulae-negative Staphylococcus, S: susceptible, I: intermediate, R: resistant.
Table 4.  Mean MIC values (mg/L) of 19 commercial antimicrobial agents used to treat bovine mastitis for the wild type and Ujosan 







































































































































































































EUCAST: European Committee on Antimicrobial Susceptibility.
conclusion was that S. aureus did not exhibit enhanced 
tolerance of chlorhexidine digluconate similar to that 
observed with the nonoxinol-9 iodine complex. 
Antimicrobial drug resistance of S. aureus strains 
and CNS 
As shown in Table 3, the S. aureus isolates showed the 
highest level of in vitro resistance to penicillin G (85.72%) 
while that of CNS was lower (28.57%), In addition 7.14% 
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of the S. aureus and CNS specimens were resistant to 
tetracycline while only 10.71% of S. aureus and 7.14% of 
CNS were resistant to gentamycin. The percentages of S. 
aureus and CNS isolates resistant to chloramphinicol were 
1.78 and 7.14%, respectively. On the other hand, all 
staphylococci strains were susceptible to oxacillin and 
erythromycin. 
Cross-resistance to teat dips and antibiotics 
The antibiotic susceptibility rates of S. aureus isolated 
from cases of bovine mastitis according to the National 
Reference Laboratory for Antibiotic Resistance (Federal 
Institute for Risk Assessment, Germany) are shown in Table 
4. All isolates showed the highest in vitro susceptibility to 
all types of antibiotics commercially available for treating 
bovine S. aureus mastitis. Resistance to antibiotics was 
observed only in a small number of strains. S. aureus F and 
H that were resistant to the nonoxinol-9 iodine complex also 
showed decreased susceptibility to penicillin G in a panel of 
different antimicrobial agents for which MIC values ranged 
from 0.25 to 2 mg/L. Additionally, no resistance to most 
antimicrobial agents was observed in the S. aureus isolates. 
Differences in MIC values did not affect the classifications 
of all strains, which were established according to the 
European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) breakpoint guidelines. 
Discussion  
The current strategy for controlling mastitis includes a 
combination of post-milking dipping and dry cow therapy 
associated with good veterinary practice of administrating 
antimicrobials to prevent or treat new infections on farms. 
However, this strategy is not always been fully successful. 
Some studies have stated that failure of these programs to 
control bovine mastitis can be partly attributed to teat 
disinfectants and/or antibiotics which do not afford 
sufficient protection against multiple pathogens that cause 
mastitis, particularly S. aureus and CNS [12,26]. Given 
that post-milking application of teat disinfectants and 
antibiotic therapy are very important tools for controlling 
bovine S. aureus mastitis, the current study concentrated 
on studying the induction of S. aureus resistance to 
different types of disinfectants as well as potential S. 
aureus cross-resistance to these teat dips and different 
types of antibiotics commonly used for treating bovine 
mastitis 
After measuring the susceptibility of S. aureus strains to 
commercial teat dips, it was observed that there were no 
significant differences between the quarters treated with 
nonoxinol-9 iodine complexes or chlorhexidine digluconate 
and the control group. This finding could be due to the fact 
that many of this pathogen has already been established in 
the udder before teat dipping [5,22]. It is not expected that 
post-milking teat dips would have any effect on previously 
established infections as reported by Whist et al. [39] who 
observed higher somatic cell counts in older cows with a 
greater prevalence of S. aureus dipped with iodine. The 
outcomes of the present study along with the effect of the 
nonoxinol-9 iodine complex and chlorhexidine digluconate 
on infected quarters need to be investigated further. 
Induction of S. aureus resistance was readily achieved by 
repeated passage with sub-lethal concentrations of the 
nonoxinol-9 iodine complex and chlorhexidine digluconate. 
Exposure to relatively low concentrations of nonoxinol-9 
iodine led to a high level of resistance within ten passages 
for most strains (90%). All strains were initially extremely 
sensitive to low concentration of the nonoxinol-9 iodine 
complex. Most subsequently acquired high levels of 
resistance after ten rounds of exposure to sub-lethal 
concentrations of the germicide. Thus, resistance to 
disinfecting agents induced by exposure to sub-lethal 
concentrations of the active compound led to significantly 
increased (p ＞ 0.001) MIC values for the nonoxinol-9 
iodine complex in most strains. However, such resistance to 
chlorhexidine digluconate was not observed except for one 
strain in which the MIC value significantly increased after 
the tenth stable passage. 
Similar findings were reported in one study for a variety of 
biocides [25]. In addition, Gilbert et al. [11] reported a 
phenotypic change resulting in resistance to several 
unrelated compounds in vitro following exposure to a low 
concentration of a biocide. Moreover, Escalada et al. [8] 
observed decreased in growth rates in Escherichia coli and 
Pseudomonas aeruginosa following exposure to sub-lethal 
concentrations of the biocide triclosan, indicating the 
generation of stress in the organism. However, the results of 
our study were different from ones obtained by Hogan and 
Smith [13] who tested eight strains of S. aureus to determine 
if repeated in vitro exposure (15 times) to sub-lethal 
concentrations of four commercial teat dips could enhance 
bacterial tolerance. They found that the responses of S. 
aureus to chlorhexidine, sodium hypochlorite, and iodophor 
were not affected by prolonged exposure to these reagents.  
Inappropriate use of antimicrobial drugs as well as biocides 
in human and veterinary medicine (needless use, incorrect 
choice, low dosage, short contact, or irregular application) is 
primarily responsible for the emergence of many resistant 
bacteria species, including staphylococci [40]. 
The Scientific Committee on Emerging and Newly 
Identified Health Risks [32] reported that bacterial 
resistance arises from a mechanism causing decreases in 
intracellular concentrations of biocides below a threshold 
level that is harmful to the bacterium. McDonnell and 
Russell [19] also found that resistance is either a hereditary 
natural property of an organism, or acquired by mutation 
and acquisition of plasmids or transposons. However, 
although the mechanisms by which bacteria resist different 
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types of antibiotics and biocides are still poorly defined, 
prolonged in vitro exposure to sub-lethal concentrations of 
antimicrobial agents undoubtedly contributes to resistance 
development. In the present study, acquired tolerance of S. 
aureus to the teat dips we tested was measured after the 
bacteria were subcultured 24 h in a media void of 
germicides and acquired stable tolerance of S. aureus to 
iodine and chlorhexidine was shown. The development of 
strains that retain resistance to a germicide in the absence 
of the compound is thought to be due to selection for or 
emergence of stable mutants. 
At present, it is unknown which mechanisms contribute 
to the adaptive resistance observed in the strains examined 
in the present study. However, this resistance is likely due 
to the presence of active efflux. This process has gained 
increased recognition as a resistance mechanism over the 
past decade and received considerable attention in recent 
years [14]. Efflux pumps decrease the intracellular 
concentration of toxic compounds [23]. These pumps are 
an important mechanism by which bacteria can evade the 
effect(s) of antimicrobial agents. The role of efflux pumps 
in the development of bacterial resistance to biocides 
might be considered modest. This is because increased 
bacterial susceptibility to selected biocides as the results of 
efflux pump expression is usually measured as an increase 
in MIC values rather than resistance to high concentrations 
of an active ingredient. Efflux pumps have been shown to 
decrease the efficacy of numerous biocides including 
quaternary ammonium compounds (Qacs), phenolic 
parabens, and intercalating agents, most notably in S. 
aureus that express pumps such as QacA-D, QacG, and 
QacH [14].  
Antimicrobial susceptibility of S. aureus isolated from 
bovine mastitis varies widely by region. In the present 
study, our results indicated that S. aureus isolates exhibited 
the highest degree of resistance to penicillin G (85.72%) 
whereas resistance to other antimicrobial agents was 
limited. This result was similar to those obtained by Shi et 
al. [34] who isolated 206 S. aureus strains from Inner 
Mongolia and found that most (87.30%) were resistant to 
penicillin.  In contrast, Aarestrup and Jensen [1] recorded a 
low penicillin resistance rate (10%) in Denmark, Norway, 
and Sweden. In the rest of the Europe, the proportion of 
penicillin-resistant isolates was found to range from 23% 
up to 69% [21]. Large scale studies on antimicrobial 
resistance of up to 5,240 bovine S. aureus isolates per year 
were conducted as part of a national monitoring program in 
Germany during 1992~1997 and found that 38 ~ 57% of the 
isolates were resistant to penicillin [21,38].
The high rate penicillin resistance amongst S. aureus 
isolated from milk of cow mastitis is likely due to the wide 
use of intramammary preparations containing combinations 
of different antibiotics and broad-spectrum antimicrobials 
[24]. Numerous factors can influence the overall 
susceptibility patterns of mastitis pathogens. Scar tissue in 
the udders of cattle chronically infected by S. aureus is an 
important factor which prevents the penetration of 
antimicrobial agents [7]. Moreover, penicillin resistance 
can be due to the expression of inducible β-lactamase 
encoded by the blaZ gene, which causes hydrolysis of the 
β-lactam ring of penicillin [34]. The first report on the 
ability of S. aureus to metabolize penicillin were published 
in 1940, a year before the antimicrobial was introduced for 
therapeutic use [23]. Impaired treatment response is 
associated with penicillin resistance of infectious S. aureus 
strains. Jones et al. [15] noted over 30 years ago that S. 
aureus isolates have relatively high MIC values for 
penicillin and ampicillin, and attributed this to β-lactamase 
inhibition of the antimicrobial drugs. β-lactamase 
production is induced in some bacteria upon exposure to β
-lactam drugs. The importance of prolonged β-lactamase- 
associated resistance in S. aureus was underscored by the 
Watts and Salmon [37] report of higher MIC values in isolates 
that produced this enzyme compared to microorganisms that 
did not. No evidence exists which suggests that this 
adaptation of S. aureus, or resistance to other classes of 
antibacterial drugs, is different from those noted 35 years 
ago. The MIC values and disk diffusion test results have 
demonstrated that ampicillin and penicillin are consistently 
the antimicrobial drugs to which S. aureus are most 
commonly resistant [37]. However, comparing values from 
one time period to another should be avoided. Any 
comparison of this kind should be done with caution because 
of differences in geography, the numbers of isolates evaluated, 
and inconsistencies in laboratory methods. For example, two 
different studies performed in the same year by Gentilini et al. 
[9] reported the proportion of oxacillin-resistant strains 
among S. aureus as 42 and 0%, respectively. 
Cross-resistance of Ujosan dip (Kesla, Germany) and 
chlorhexidine digluconate-resistant S. aureus to a panel of 
antibiotics was investigated among 29 strains. When MIC 
values for the susceptible and adapted strains were 
determined by the microdilution method, S. aureus strains 
that had adapted to the Ujosan dip and chlorhexidine 
digluconate were found to be susceptible to all tested 
antibiotics. Differences in MIC values did not affect 
classifications of all strains, which were all susceptible to 
antimicrobial agents according to EUCAST breakpoint 
guidelines. Similar findings were reported by Jurgens et 
al. [16], Birošová and Mikulášová [2], and Cottell et al. 
[6]. However, our result was not in agreement with those 
obtained by Karatzas et al. [17] or Randall et al. [27]. They 
observed cross-resistance among bacterial species with 
reduced susceptibility to biocides and antibiotic resistance. 
There is no indication from these results suggesting that 
strains resistant to nonoxinol-9 iodine complexes and 
chlorhexidine digluconate are also resistant to antibiotics 
according to EUCAST. The association between biocide 
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non-susceptibility and antibiotic resistance is still unclear. 
Several investigators were able to demonstrate cross- 
resistance between antibiotics and biocides. However, when 
cross-resistance was identified, it was often reported for 
second-line drugs or compounds not usually used for 
therapeutic purposes [17]. Moreover, nearly all of this 
research has been performed in the laboratory, and thus may 
not accurately reflect real world situations. These studies 
only examined antibiotic and biocide sensitivities in vitro. A 
lack of cross-resistance of the nonoxinol-9 iodine complex 
and chlorhexidine digluconate-resistant mutants to the 
antibiotics tested in this study suggested that the 
mechanisms underlying resistance to biocides are distinct 
from those affecting antibiotic resistance.
Although bacterial susceptibilities to antimicrobial drugs 
are well characterized, the relevance of changes in the MIC 
of an antiseptic is currently unknown. Even so, Rogers [28] 
noted that growing bacterial isolates in sub-lethal 
concentrations of biocide can induce changes in the profile 
of antibiotic susceptibility, especially if changes in biocide 
susceptibilities can be related to therapeutic levels of 
antibiotics. Multiple studies have suggested that an efflux 
mechanism is involved in biocide resistance [19,29].  
Current knowledge of efflux mechanisms suggests that 
these pumps can utilize a variety of substrates, including 
antibiotics and biocides, and therefore may represent a 
problem in induction of resistance to different antimicrobial 
agents. There is incomplete understanding as to whether the 
use of biocides might give rise to resistance to currently 
used antibiotics, or prevent the development of new 
antibiotics. Clearly, more research is needed to characterize 
the relationship between biocide non-susceptibility and 
antibiotic resistance. Based on the results from the present 
study, resistance of S. aureus to chemical disinfectants may 
be more likely to develop if these compounds are used at 
concentrations lower than ones required for optimal 
biocidal effects. This reinforces the importance of always 
using disinfectants at the recommended concentrations and 
according to the manufacturer's directions. 
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